Positron Emission Tomography (PET) Scanners Are Advanced Medical Imaging Devices That Use Positron-Emitting Radiotracers To Visualize And Measure Physiological Processes In The Body
One of the primary applications of Positron Emission Tomography (PET) Scanners is in oncology. PET imaging plays a crucial role in cancer diagnosis, staging, and treatment monitoring. By using specific radiotracers, such as fluorodeoxyglucose (FDG), which is a glucose analog, PET scans can identify areas of increased glucose metabolism. Cancer cells typically exhibit higher metabolic rates than normal cells, leading to increased FDG uptake. This increased uptake is visualized as "hot spots" on the PET scan, indicating the presence of cancerous lesions. PET scans can help detect primary tumors, identify metastases, and guide biopsy procedures by targeting the most active regions.
Moreover, Positron Emission Tomography (PET) Scanners imaging allows for the evaluation of treatment response in cancer patients. By comparing PET scans before and after therapy, clinicians can assess the effectiveness of chemotherapy, radiation therapy, or targeted therapies. Changes in metabolic activity and tumor size provide crucial information for modifying treatment plans and predicting patient outcomes. PET scans can also aid in the early detection of recurrence, often before it becomes detectable by conventional imaging methods, enabling timely intervention.
Read More http://latestcmiblogs.weebly.com/article/positron-emission-tomography-pet-scanners-work-by-detecting-and-visualizing-the-distribution-of-radioactive-tracers-injected-into-the-patients-body